Brief: Cytek Biosciences Reports Second Quarter 2022 Financial Results
Aug 10 (Reuters) - Cytek Biosciences Inc CTKB.O :
* CYTEK BIOSCIENCES REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
* Q2 REVENUE ROSE 32 PERCENT TO $40.2 MILLION
* QTRLY LOSS PER SHARE $0.00
* CONTINUES TO EXPECT FULL YEAR 2022 REVENUE TO BE CLOSER TO
THE
HIGH END OF THE RANGE OF $160 MILLION TO $168 MILLION
Source text for Eikon: ID:nGNX65Qcmz
Further company coverage: CTKB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million